ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
8,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
11,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
11,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,6,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
11,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
12,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
14,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
15,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
15,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
16,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
16,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
17,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
18,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
18,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
19,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
19,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
20,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
21,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
22,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
22,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
22,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,5,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
23,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
23,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
23,3,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
24,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
24,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
24,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
25,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
27,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
27,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,3,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
27,4,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,5,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
27,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,8,Headache,Headaches NEC,Headaches,Nerv,N
27,9,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
27,10,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
28,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
28,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
29,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
29,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
29,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
29,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
30,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
30,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
31,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
32,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
32,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
32,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
33,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
34,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
35,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
36,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
36,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
37,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
37,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
37,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
38,1,Adenocarcinoma of the cervix,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
39,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
39,3,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
40,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
41,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
42,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
42,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
42,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,5,Tension headache,Headaches NEC,Headaches,Nerv,N
43,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
44,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
44,2,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
44,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
45,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
46,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,2,Hepatitis B core antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
47,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
47,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
47,4,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
48,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
48,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
48,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
48,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
48,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
49,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
49,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
50,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
50,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
51,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
52,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
53,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
53,2,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
53,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
54,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
54,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
55,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
56,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
56,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
57,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
58,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
59,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
60,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
60,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
60,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
60,4,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
61,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
61,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
62,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
62,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
63,1,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
64,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
65,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
66,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
66,2,Blood bicarbonate increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
66,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
66,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
66,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
67,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
68,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
69,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
69,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
70,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
70,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,1,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
71,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
73,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
74,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
75,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
75,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
76,1,Gastrointestinal melanoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
77,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
78,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,3,Headache,Headaches NEC,Headaches,Nerv,N
78,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
78,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
79,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
79,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
79,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
79,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
79,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
79,6,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
79,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
79,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,9,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
79,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
80,2,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
81,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
82,1,Cervix carcinoma stage III,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
82,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
83,1,Bladder cancer stage II,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
84,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
85,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
86,1,Cervix carcinoma stage 0,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
86,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
87,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
88,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
88,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
89,1,Headache,Headaches NEC,Headaches,Nerv,N
89,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
90,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
91,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
92,1,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
93,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
93,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
94,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
94,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
94,3,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
94,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
94,5,Headache,Headaches NEC,Headaches,Nerv,N
94,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
94,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
94,8,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
94,9,Red blood cell count increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
94,10,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
94,11,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
94,12,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
94,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
95,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
95,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
95,3,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
95,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
96,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
97,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
97,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
97,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
98,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
99,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
99,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
99,4,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
99,5,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
99,6,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
100,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
100,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
101,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
101,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
102,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
102,2,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
102,3,Carbohydrate antigen 125 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
102,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
103,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
104,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
105,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
105,2,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
105,3,Calcium ionised increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
105,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
105,5,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
105,6,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
105,7,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
105,8,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
105,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
106,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
107,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
107,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
107,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
108,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
108,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
109,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
110,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
110,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
111,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
112,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
112,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
113,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
114,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
115,1,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
116,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
116,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
117,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
118,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
118,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
118,3,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
118,4,Madarosis,Alopecias,Skin appendage conditions,Skin,N
118,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
119,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
119,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
121,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
122,1,Granuloma annulare,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
123,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
124,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
125,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
125,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
125,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
125,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
126,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
126,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
126,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
127,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
127,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
128,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
129,1,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
130,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
130,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,3,Headache,Headaches NEC,Headaches,Nerv,N
130,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
130,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
130,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
130,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
130,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
130,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
131,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
131,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
131,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
131,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
131,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
131,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
132,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
132,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
133,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
133,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
133,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
133,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
133,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
134,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
134,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
134,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
134,5,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
134,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
134,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
134,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
134,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
134,10,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
134,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
135,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
135,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
135,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
137,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
138,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
138,2,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
138,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
138,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
138,5,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
138,6,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
138,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
138,8,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
139,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
140,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
141,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
142,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
143,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
143,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
143,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
143,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
144,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
144,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
145,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
146,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
146,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
146,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
146,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
146,5,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
146,6,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
146,7,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
146,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
146,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
146,10,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
146,11,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
146,12,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
146,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
146,14,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
146,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
146,16,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
146,17,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
146,18,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
146,19,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
146,20,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
146,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
146,22,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
146,23,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
146,24,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
146,25,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
147,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
148,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
148,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
148,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
149,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
150,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
151,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
152,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
153,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
153,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
153,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
153,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
153,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
154,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
155,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
155,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
155,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
156,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
156,2,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
157,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
158,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
158,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
158,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
158,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
160,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
160,2,Dyspareunia,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
160,3,Headache,Headaches NEC,Headaches,Nerv,N
161,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
162,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
162,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
163,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
164,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
164,2,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
164,3,Blood alkaline phosphatase abnormal,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
164,4,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
164,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
164,6,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
164,7,Body mass index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
164,8,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
164,9,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
164,10,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
164,11,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
164,12,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
164,13,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
164,14,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
164,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
164,16,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
165,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
166,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
167,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
168,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
168,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
168,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
169,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
169,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
169,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
169,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
170,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
170,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
170,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
170,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
170,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
170,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
171,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
172,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
173,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
174,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
175,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
176,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
176,2,Vulval ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
177,1,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
178,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
179,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
180,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
180,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
180,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
180,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
181,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
181,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
181,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
181,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
182,1,Acne,Acnes,Skin appendage conditions,Skin,N
182,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
182,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
182,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
182,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
183,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
184,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
185,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
186,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
186,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
186,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
186,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
187,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
188,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
188,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
189,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
189,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
191,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
191,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
192,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
193,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
194,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
194,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
194,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
194,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
195,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
196,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
196,2,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
197,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
197,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
197,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
198,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
198,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
199,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
199,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
199,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
199,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
199,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
200,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
201,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
201,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
202,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
203,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
204,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
204,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
204,4,Headache,Headaches NEC,Headaches,Nerv,N
204,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
205,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
205,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
206,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
207,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
207,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
207,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
208,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
208,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
208,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
208,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
208,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
210,1,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
211,1,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
212,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
212,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
213,1,Headache,Headaches NEC,Headaches,Nerv,N
213,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
214,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
214,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
214,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
214,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
214,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
215,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
215,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
216,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
216,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
217,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
217,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
217,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
218,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
218,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
218,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,1,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
219,2,Smear site unspecified abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
220,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
220,2,Headache,Headaches NEC,Headaches,Nerv,N
221,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
222,1,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
222,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
223,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
224,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
224,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
224,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
224,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
225,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
226,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
226,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
227,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
228,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
228,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
228,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
229,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
229,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
230,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
230,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
231,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
231,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
232,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
233,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
233,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
233,3,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
233,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
233,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
233,9,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,10,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
233,11,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
234,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
235,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
236,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
236,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
236,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
236,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
237,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
237,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
237,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
237,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
238,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
239,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
239,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
239,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
240,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
241,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
241,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
242,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
243,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
244,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
244,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
245,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
245,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
246,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
246,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
247,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
247,2,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
247,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
247,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
247,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
248,1,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
248,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
249,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
250,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
251,1,Head banging,Stereotypies and automatisms,Changes in physical activity,Psych,N
252,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
253,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
254,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
254,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
255,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
255,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
257,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
258,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
258,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
258,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
258,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
259,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
259,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
260,1,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
261,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
261,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
262,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
262,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
262,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
263,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
263,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
263,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
263,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
263,5,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
264,1,Headache,Headaches NEC,Headaches,Nerv,N
264,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
264,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
264,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
265,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
265,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
265,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
265,4,Urinary tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
266,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
267,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
267,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
267,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
268,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
269,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
269,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
270,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
270,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
270,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
271,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
271,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
272,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
272,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
273,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
273,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
274,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,2,Headache,Headaches NEC,Headaches,Nerv,N
274,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
275,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
276,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
277,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
278,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
278,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
278,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
278,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
278,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
279,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
280,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
280,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
281,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
281,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
282,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
283,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
283,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
284,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
285,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
285,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
285,3,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
285,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
286,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
286,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
286,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
286,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
286,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
287,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
287,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
287,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
287,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
288,1,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
289,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
290,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
290,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
291,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
291,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
291,3,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
291,4,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
291,5,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
291,6,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
291,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
291,8,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
292,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
293,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
294,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
294,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
294,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
295,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
296,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
297,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
297,2,Headache,Headaches NEC,Headaches,Nerv,N
297,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
297,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
297,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
298,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
298,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
298,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
298,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
298,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
298,6,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
299,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
299,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
299,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
299,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
300,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
302,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
302,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
303,1,Headache,Headaches NEC,Headaches,Nerv,N
303,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
303,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
304,1,Ruptured cerebral aneurysm,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
305,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
305,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
306,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
306,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
306,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
306,4,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
307,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
307,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
308,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
309,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
309,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
310,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
310,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
310,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
310,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
311,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
312,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
312,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
313,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
314,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
315,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
316,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
316,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
317,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
317,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
317,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
317,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
317,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
318,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
318,2,Derealisation,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
318,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
318,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
318,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
318,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
318,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
319,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
320,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
320,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
321,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
322,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
323,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
323,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
324,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
325,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
325,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
325,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
325,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,5,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
325,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
325,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
325,8,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
325,9,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
325,10,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
325,11,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
325,12,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
325,13,Large intestine infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
325,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
325,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
326,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
326,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
327,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
328,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
328,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
328,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
329,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
329,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
329,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
329,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
329,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
329,6,Headache,Headaches NEC,Headaches,Nerv,N
330,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
330,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
331,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
332,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
333,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
333,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
334,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
334,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
334,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
335,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
336,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
336,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
336,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
336,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
336,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
337,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
337,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
337,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
338,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
339,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
340,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
340,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
340,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
340,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
340,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
341,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
342,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
343,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
343,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
343,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
343,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
344,1,Headache,Headaches NEC,Headaches,Nerv,N
345,1,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
346,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
346,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
346,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
346,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
346,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
347,1,Nail psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
347,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
347,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
348,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
349,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
349,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
349,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
349,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
349,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
350,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
351,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
351,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
352,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
352,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
352,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
353,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
354,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
355,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
356,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
357,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
357,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
358,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
359,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
359,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
359,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
360,1,Pigmentation lip,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
361,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
362,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
363,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
363,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
363,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
364,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
365,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
366,1,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
366,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
367,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
367,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
368,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
368,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
368,3,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
368,4,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
368,5,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
369,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
369,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
370,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
370,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
371,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
371,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
371,3,Band sensation,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
371,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
371,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
372,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
372,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
373,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
374,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
375,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
375,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
376,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
376,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
377,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
377,2,Headache,Headaches NEC,Headaches,Nerv,N
377,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
377,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
377,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
378,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
379,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
380,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
380,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,4,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
381,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
381,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,3,Gait spastic,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
381,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
381,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
381,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
382,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
382,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
382,3,Headache,Headaches NEC,Headaches,Nerv,N
382,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
382,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
382,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
383,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
384,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
385,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
386,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
386,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
386,3,Headache,Headaches NEC,Headaches,Nerv,N
386,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
386,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
387,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
388,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
389,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
390,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
390,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
391,1,Headache,Headaches NEC,Headaches,Nerv,N
391,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
392,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
392,3,Headache,Headaches NEC,Headaches,Nerv,N
392,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
392,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
393,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
394,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
395,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
396,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
396,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
396,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
397,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
398,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
398,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
399,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
400,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
401,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
401,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
401,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
401,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
402,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
402,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
403,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
403,2,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
404,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
405,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
406,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
406,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
406,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
406,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
407,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
408,1,Headache,Headaches NEC,Headaches,Nerv,N
408,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
409,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
409,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
410,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
410,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
411,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
411,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
412,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
413,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
414,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
414,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
414,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
415,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
415,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
415,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
415,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
416,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
416,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
416,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
416,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
417,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
418,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
419,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
419,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
420,1,Xanthelasma,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
421,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
421,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
421,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
421,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
421,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
421,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
421,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
421,8,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
421,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
421,10,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
422,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
422,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
422,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
422,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
423,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
424,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
425,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
426,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
427,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
428,1,Xanthelasma,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
429,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
430,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
431,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
431,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
431,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
432,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
433,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
434,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
434,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
434,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
434,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
434,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
434,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
434,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
434,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
435,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
435,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
435,3,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
436,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
436,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
437,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
438,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
438,2,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
439,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
439,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
440,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
440,2,Tendon injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
441,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
441,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
442,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
442,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
443,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
444,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
445,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
446,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
447,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
448,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
449,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
450,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
450,2,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
451,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
451,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
452,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
453,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
453,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
454,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
454,2,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
455,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
455,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
455,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
456,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
456,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
457,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
458,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
458,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
459,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
459,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
460,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
460,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
460,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
461,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
462,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
463,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
463,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
464,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
465,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
465,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
466,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
467,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
467,2,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
467,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
467,4,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
468,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
468,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
468,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
469,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
469,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
470,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
470,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
470,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
470,4,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
470,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
470,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
471,1,Rehabilitation therapy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
471,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
472,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
472,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
473,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
473,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
473,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
474,1,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
475,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
476,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
477,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
477,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
478,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
478,2,Hand deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
479,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
479,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
480,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
481,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
481,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
481,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
481,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
481,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
481,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
481,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
482,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
482,2,Onychalgia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
482,3,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
483,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
484,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
485,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
486,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
487,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
488,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
488,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
489,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
490,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
490,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
491,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
492,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
493,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
494,1,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
495,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
496,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
496,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
497,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
497,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
498,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
499,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
500,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
501,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
502,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
502,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
502,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
503,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
504,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
505,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
506,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
507,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
508,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
509,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
510,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
510,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
511,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
512,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
513,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
513,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
514,1,Expanded disability status scale score increased,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
515,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
515,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
515,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
515,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
515,5,Headache,Headaches NEC,Headaches,Nerv,N
516,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
516,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
517,1,Cystitis noninfective,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
518,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
518,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
518,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
519,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
520,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
521,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
522,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
523,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
524,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
525,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
526,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
526,2,Band sensation,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
526,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
527,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
527,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
527,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
527,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
527,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
528,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
528,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
529,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
530,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
531,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
531,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
532,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
533,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
533,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
534,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
535,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
536,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
536,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
536,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
536,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
536,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
537,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
538,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
538,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
538,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
539,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
539,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
540,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
541,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
541,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
541,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
541,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
541,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
542,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
543,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
543,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
543,3,Anti-glomerular basement membrane disease,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
543,4,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
543,5,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
543,6,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
543,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
543,8,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
543,9,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
543,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
543,11,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
543,12,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
543,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
543,14,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
543,15,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
543,16,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
543,17,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
543,18,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
543,19,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
543,20,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
543,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
543,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
543,23,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
543,24,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
543,25,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
543,26,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
544,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
545,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
545,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
546,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
547,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
547,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
547,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
548,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
549,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
550,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
551,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
552,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
553,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
553,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
554,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
555,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
555,2,Bladder discomfort,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
555,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
556,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
557,1,Azoospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
557,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
557,3,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
557,4,Testicular disorder,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
557,5,Varicocele,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
558,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
559,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
560,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
560,2,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
561,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
562,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
563,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
564,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
564,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
565,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
566,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
566,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
566,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
566,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
567,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
567,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
568,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
569,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
569,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
569,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
570,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
570,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
570,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
570,4,Headache,Headaches NEC,Headaches,Nerv,N
570,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
571,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
571,2,Madarosis,Alopecias,Skin appendage conditions,Skin,N
571,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
571,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
572,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
573,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
574,1,Headache,Headaches NEC,Headaches,Nerv,N
575,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
576,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
576,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
576,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
577,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
578,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
579,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
580,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
580,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
581,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
582,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,2,Drug level abnormal,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
582,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
582,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
582,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
583,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
584,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
585,1,Progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
586,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
586,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
586,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
586,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
586,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
587,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
588,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
589,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
590,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
590,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
590,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
590,4,Headache,Headaches NEC,Headaches,Nerv,N
590,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
590,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
590,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
590,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
591,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
592,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
592,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
592,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
592,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
592,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
593,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
594,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
594,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
595,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
596,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
597,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
598,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
598,2,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
598,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
599,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
599,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
600,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
601,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
601,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
602,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
602,2,Shoulder operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
603,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
604,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
604,2,Menopause,Age related issues,Age related factors,SocCi,N
605,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
605,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
605,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
605,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
605,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
605,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
606,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
606,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
607,1,Disease complication,General signs and symptoms NEC,General system disorders NEC,Genrl,N
607,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
608,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
609,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
610,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
610,2,Oesophageal disorder,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
611,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
611,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
612,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
612,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
613,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
614,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
614,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
615,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
616,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
617,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
618,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
619,1,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
619,2,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
619,3,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
619,4,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
619,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
620,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
621,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
622,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
622,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
622,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
623,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
624,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
625,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
625,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
625,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
626,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
626,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
627,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
628,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
629,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
629,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
630,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
630,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
631,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
632,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
633,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
634,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
634,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
634,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
634,4,Migraine,Migraine headaches,Headaches,Nerv,N
634,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
634,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
635,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
635,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
636,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
637,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
637,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
637,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
638,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
639,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
640,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
641,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
642,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
642,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
643,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
644,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
645,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
646,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
647,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
648,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
648,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
648,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
649,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
650,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
651,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
652,1,Disability,Disability issues,Lifestyle issues,SocCi,N
653,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
654,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
655,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
656,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
656,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
656,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
656,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
656,5,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
656,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
657,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
657,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
658,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
659,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
659,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
660,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
660,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
661,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
662,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
663,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
663,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
664,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
664,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
665,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
666,1,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
666,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
667,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
667,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
668,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
669,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
670,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
671,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
672,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
673,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
673,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
674,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
675,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
675,2,Nail psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
675,3,Yellow nail syndrome,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
676,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
677,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
678,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
678,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
678,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
678,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
678,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
679,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
679,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
680,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
680,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
681,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
682,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
682,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
682,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
682,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
682,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
682,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
683,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
683,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
684,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
685,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
685,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
685,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
686,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
686,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
687,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
687,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
688,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
689,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
690,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
691,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
692,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
693,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
693,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
694,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
695,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
696,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
697,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
697,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
697,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
697,4,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
697,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
698,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
699,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
700,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
700,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
701,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
702,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
703,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
703,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
703,3,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
703,4,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
703,5,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
704,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
705,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
